Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Disanto

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Expert Review of Neurotherapeutics|August 26, 2011
Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?Giulio Disanto, Ute Meier, Gavin Giovannoni, et al.
American Journal of Epidemiology|March 15, 2012
Re: "Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study"Antonio J Berlanga-Taylor, Giulio Disanto, Sreeram V Ramagopalan
Journal of Neurology|November 3, 2010
The emerging role of vitamin D binding protein in multiple sclerosisGiulio Disanto, Sreeram V Ramagopalan, Andrea E Para, et al.
Annals of Neurology|June 11, 2025
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple SclerosisGiulio Disanto, Rosaria Sacco, Giulia Mallucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2011
Comment on "Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice"Giulio Disanto, Adam E Handel, Julia M Morahan, et al.
BMC Neurology|July 14, 2019
Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patientsChiara Zecca, Giulio Disanto, Rosaria Sacco, et al.
JAMA Neurology|September 10, 2014
Alcohol misuse disorders and multiple sclerosis riskJulia Pakpoor, Raph Goldacre, Giulio Disanto, et al.
Journal of Neurology|April 17, 2013
Cytomegalovirus and multiple sclerosis riskJulia Pakpoor, Jina Pakpoor, Giulio Disanto, et al.
Journal of Clinical Medicine|September 9, 2023
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis OpticaJennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Plos One|May 15, 2018
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern SwitzerlandBarbara Scotti, Giulio Disanto, Rosaria Sacco, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Expert Review of Neurotherapeutics|August 26, 2011
Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?Giulio Disanto, Ute Meier, Gavin Giovannoni, et al.
American Journal of Epidemiology|March 15, 2012
Re: "Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study"Antonio J Berlanga-Taylor, Giulio Disanto, Sreeram V Ramagopalan
Journal of Neurology|November 3, 2010
The emerging role of vitamin D binding protein in multiple sclerosisGiulio Disanto, Sreeram V Ramagopalan, Andrea E Para, et al.
Annals of Neurology|June 11, 2025
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple SclerosisGiulio Disanto, Rosaria Sacco, Giulia Mallucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2011
Comment on "Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice"Giulio Disanto, Adam E Handel, Julia M Morahan, et al.
BMC Neurology|July 14, 2019
Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patientsChiara Zecca, Giulio Disanto, Rosaria Sacco, et al.
JAMA Neurology|September 10, 2014
Alcohol misuse disorders and multiple sclerosis riskJulia Pakpoor, Raph Goldacre, Giulio Disanto, et al.
Journal of Neurology|April 17, 2013
Cytomegalovirus and multiple sclerosis riskJulia Pakpoor, Jina Pakpoor, Giulio Disanto, et al.
Journal of Clinical Medicine|September 9, 2023
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis OpticaJennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Plos One|May 15, 2018
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern SwitzerlandBarbara Scotti, Giulio Disanto, Rosaria Sacco, et al.
Pageof 13